204 related articles for article (PubMed ID: 32815156)
1. Triptorelin for the treatment of adenomyosis: A multicenter observational study of 465 women in Russia.
Andreeva E; Absatarova Y
Int J Gynaecol Obstet; 2020 Dec; 151(3):347-354. PubMed ID: 32815156
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of triptorelin-therapy following conservative surgery for deep infiltrating endometriosis: A multicenter, prospective, non-interventional study in China.
Zhu L; Guan Z; Huang Y; Hua K; Ma L; Zhang J; Yang D; Perrot V; Li H; Zhang X
Medicine (Baltimore); 2022 Feb; 101(5):e28766. PubMed ID: 35119037
[TBL] [Abstract][Full Text] [Related]
3. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.
Niu X; Luo Q; Wang C; Zhu L; Huang L
Medicine (Baltimore); 2021 Feb; 100(6):e24597. PubMed ID: 33578561
[TBL] [Abstract][Full Text] [Related]
4. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles.
Bourdon M; Oliveira J; Marcellin L; Santulli P; Bordonne C; Maitrot Mantelet L; Millischer AE; Plu Bureau G; Chapron C
Hum Reprod; 2021 Jan; 36(2):349-357. PubMed ID: 33491057
[TBL] [Abstract][Full Text] [Related]
5. Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis: study protocol for a multicenter, prospective, randomized controlled trial.
Wang W; Ma X; Zhang W; Li Z; Wang Y; Yu Z; Zhang C; Hong L; Luo R; Xing H; Wang W; Yue Q; Wei J; Zhang M; Wang S
Trials; 2020 Apr; 21(1):364. PubMed ID: 32345377
[TBL] [Abstract][Full Text] [Related]
6. Guideline No. 437: Diagnosis and Management of Adenomyosis.
Dason ES; Maxim M; Sanders A; Papillon-Smith J; Ng D; Chan C; Sobel M
J Obstet Gynaecol Can; 2023 Jun; 45(6):417-429.e1. PubMed ID: 37244746
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing adenomyosis: an integrated clinical and imaging approach.
Chapron C; Vannuccini S; Santulli P; Abrão MS; Carmona F; Fraser IS; Gordts S; Guo SW; Just PA; Noël JC; Pistofidis G; Van den Bosch T; Petraglia F
Hum Reprod Update; 2020 Apr; 26(3):392-411. PubMed ID: 32097456
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.
Li X; Li H; Shi H; Li X; Zhou R; Lu D; Cai Y; Zhou Y; Cabri P; Shi X; Pedret-Dunn A; Leng J
Adv Ther; 2022 Oct; 39(10):4663-4677. PubMed ID: 35947347
[TBL] [Abstract][Full Text] [Related]
9. Adenomyosis: Diagnosis and Management.
Schrager S; Yogendran L; Marquez CM; Sadowski EA
Am Fam Physician; 2022 Jan; 105(1):33-38. PubMed ID: 35029928
[TBL] [Abstract][Full Text] [Related]
10. Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial.
Sharma S; RoyChoudhury S; Bhattacharya MP; Hazra S; Majhi AK; Oswal KC; Chattopadhyay R
Reprod Biomed Online; 2023 Jul; 47(1):84-93. PubMed ID: 37149412
[TBL] [Abstract][Full Text] [Related]
11. Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up.
Carrillo Torres P; Martínez-Zamora MÁ; Ros C; Rius M; Mensión E; Gracia M; Carmona F
Sci Rep; 2023 Feb; 13(1):2066. PubMed ID: 36739298
[TBL] [Abstract][Full Text] [Related]
12. Symptom control after different duration of triptorelin treatment following conservative surgery for deep infiltrating endometriosis: Post-hoc analysis of a multicentre, prospective, real-world study.
Sun W; Hua K; Hong L; Zhang J; Hao M; Wang J; Zhang J; Perrot V; Li H; Zhang X
Medicine (Baltimore); 2021 Jul; 100(30):e26753. PubMed ID: 34397719
[TBL] [Abstract][Full Text] [Related]
13. A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain.
Alshehre SM; Duffy S; Jones G; Ledger WL; Metwally M
Reprod Biol Endocrinol; 2020 Apr; 18(1):28. PubMed ID: 32290838
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Quality of Life, Sexual Quality of Life, and Pain Symptoms in Deep Infiltrating Endometriosis Patients With or Without Associated Adenomyosis and the Influence of a Flexible Extended Combined Oral Contraceptive Regimen: Results of a Prospective, Observational Study.
Alcalde AM; Martínez-Zamora MÁ; Gracia M; Ros C; Rius M; Castelo-Branco C; Carmona F
J Sex Med; 2022 Feb; 19(2):311-318. PubMed ID: 34974988
[TBL] [Abstract][Full Text] [Related]
15. Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions.
Vercellini P; Bandini V; Viganò P; Ambruoso D; Cetera GE; Somigliana E
Hum Reprod; 2024 Jan; 39(1):18-34. PubMed ID: 37951241
[TBL] [Abstract][Full Text] [Related]
16. Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trials.
Pokrzywinski RM; Soliman AM; Chen J; Snabes MC; Coyne KS; Surrey ES; Taylor HS
Am J Obstet Gynecol; 2020 Jun; 222(6):592.e1-592.e10. PubMed ID: 31759891
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of a novel method of fertility-preserving adenomyomectomy in infertile women with diffuse adenomyosis.
Yoon SH; Lee GJ; Cho HJ; Kwon H; Yun BS; Lee CH; Park HS; Roh JW
Medicine (Baltimore); 2023 Mar; 102(13):e33266. PubMed ID: 37000061
[TBL] [Abstract][Full Text] [Related]
18. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015.
Yu O; Schulze-Rath R; Grafton J; Hansen K; Scholes D; Reed SD
Am J Obstet Gynecol; 2020 Jul; 223(1):94.e1-94.e10. PubMed ID: 31954156
[TBL] [Abstract][Full Text] [Related]
19. Heat can treat: long-term follow-up results after uterine-sparing treatment of adenomyosis with radiofrequency thermal ablation in 60 hysterectomy candidate patients.
Stepniewska AK; Baggio S; Clarizia R; Bruni F; Roviglione G; Ceccarello M; Manzone M; Guerriero M; Ceccaroni M
Surg Endosc; 2022 Aug; 36(8):5803-5811. PubMed ID: 35024930
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
